I 
118TH CONGRESS 
2D SESSION 
H. R. 8570 
To establish a pharmacy program to award grants for safe in-home drug 
disposal and practical medication safety education, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 24, 2024 
Mr. HUDSON introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To establish a pharmacy program to award grants for safe 
in-home drug disposal and practical medication safety 
education, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Safe In-Home Drug 
Disposal Initiative Act of 2024’’ or the ‘‘SIDDI Act of 
2024’’. 
SEC. 2. SAFE IN-HOME DRUG DISPOSAL INITIATIVE. 
(a) IN GENERAL.—Not later than 180 days after the 
date of enactment of this Act, the Secretary of Health and 
Human Services, acting through the Assistant Secretary 
VerDate Sep 11 2014 
03:34 Jul 27, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8570.IH
H8570
kjohnson on DSK7ZCZBW3PROD with $$_JOB
for Mental Health and Substance Use, (in this section re-
ferred to as the ‘‘Secretary’’) shall establish a program 
to award grants to States to implement targeted State 
demonstration initiatives (in this section referred to as 
‘‘TSDIs’’). Such TSDIs shall reimburse licensed phar-
macies that choose to participate in the TSDI (in this sec-
tion referred to as ‘‘participating pharmacies’’) for the 
provision to eligible patients, in coordination with the de-
livery of drug prescriptions, of in-home drug disposal sys-
tems and standard medication safety education. 
(b) APPLICATION.—To be eligible to receive a grant 
under this section, a State shall submit to the Secretary 
an application at such time, in such manner, and con-
taining such information as the Secretary may require. 
Such an application shall— 
(1) identify the State agency that oversees 
pharmaceutical care and will be responsible for ad-
ministering a TSDI through a grant under this sec-
tion; 
(2) identify the single pharmacy benefit man-
ager (commonly known as a ‘‘PBM’’) that will be re-
sponsible for— 
(A) adjudicating claims under the TSDI; 
(B) reimbursing participating pharmacies; 
and 
VerDate Sep 11 2014 
03:34 Jul 27, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8570.IH
H8570
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(C) facilitating the type of customization 
required to successfully administer a custom, 
fully transparent program, with pass-through 
claims adjudication services benefitting pa-
tients, plans, and pharmacies; 
(3) outline the process by which participating 
pharmacies will submit usual and customary costs 
related to the reimbursement and remuneration of 
services, including detailed reporting on— 
(A) criteria of patient selection; 
(B) initial activity; and 
(C) patient engagement factors; 
(4) detail the process through which standard 
medication safety education will be communicated by 
each participating pharmacist or pharmacy techni-
cian at the point of dispensing, allowing for unique 
needs and education to be tailored for State-, coun-
ty-, town-, and municipality-specific needs; 
(5) detail a plan to increase participation rates 
of pharmacists and pharmacy technicians through a 
single electronic pharmacy claim process; 
(6) state the remuneration amounts for the pro-
vision of standard medication safety education, and 
the reimbursement amounts for in-home drug dis-
posal systems, which for each eligible patient shall 
VerDate Sep 11 2014 
03:34 Jul 27, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8570.IH
H8570
kjohnson on DSK7ZCZBW3PROD with $$_JOB